Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order

EGFR

epidermal growth factor receptor

Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, amphiregulin, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF. Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. May also activate the NF-kappa-B signaling cascade. Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling. Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin.Isoform 2 may act as an antagonist of EGF action.

Gene Name: epidermal growth factor receptor
Family/Subfamily: Protein Kinase , EGF Receptor
Synonyms: EGFR, EGF Receptor, ERBB, ERBB1, MENA, PIG61, Proto-oncogene c-ErbB-1, V-erb-b homolog, EGF-R, HER1
Target Sequences: NM_005228 NP_005219.2 P00533

Publications (11)

1
Perinatal increases in TGF-{alpha} disrupt the saccular phase of lung morphogenesis and cause remodeling: microarray analysis. Kramer EL, Deutsch GH, Sartor MA, Hardie WD, Ikegami M, Korfhagen TR, Le Cras TD. American journal of physiology. Lung cellular and molecular physiology. 2007 293:L314-27. (WB) [PubMed:17468132]
2
Multipathway model enables prediction of kinase inhibitor cross-talk effects on migration of Her2-overexpressing mammary epithelial cells. Kumar N, Afeyan R, Kim HD, Lauffenburger DA. Molecular pharmacology. 2008 73:1668-78. (ICC) [PubMed:18349105]
3
Acrolein increases 5-lipoxygenase expression in murine macrophages through activation of ERK pathway. Kim CE, Lee SJ, Seo KW, Park HM, Yun JW, Bae JU, Bae SS, Kim CD. Toxicology and applied pharmacology. 2010 245:76-82. (WB) [PubMed:20153347]
4
Nuclear translocation of type I transforming growth factor receptor confers a novel function in RNA processing. Chandra M, Zang S, Li H, Zimmerman LJ, Champer J, Tsuyada A, Chow A, Zhou W, Yu Y, Gao H, Ren X, Lin RJ, Wang SE. Molecular and cellular biology. 2012 32:2183-95. [PubMed:22473997] [PMC:PMC3372271]
5
Liquid crystal droplet-based amplification of microvesicles that are shed by mammalian cells. Tan LN, Wiepz GJ, Miller DS, Shusta EV, Abbott NL. The Analyst. 2014 139:2386-96. (WB; Human) [Full Text Article] [PubMed:24667742] [PMC:PMC4212983]
6
HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone. Day KC, Lorenzatti Hiles G, Kozminsky M, Dawsey SJ, Paul A, Broses LJ, Shah R, Kunja LP, Hall C, Palanisamy N, Daignault-Newton S, El-Sawy L, Wilson SJ, Chou A, Ignatoski KW, Keller E, Thomas D, Nagrath S, Morgan T, Day ML. Cancer research. 2017 77:74-85. (IP; Human) [Full Text Article] [PubMed:27793843] [PMC:PMC5214538]
7
Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody. Reilly EB, Phillips AC, Buchanan FG, Kingsbury G, Zhang Y, Meulbroek JA, Cole TB, DeVries PJ, Falls HD, Beam C, Gu J, Digiammarino EL, Palma JP, Donawho CK, Goodwin NC, Scott AM. Molecular cancer therapeutics. 2015 14:1141-51. (WB; Human) [Full Text Article] [PubMed:25731184] Related Antibodies: LS-C6625.
8
Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2. Nikolakopoulou Z, Nteliopoulos G, Michael-Titus AT, Parkinson EK. Carcinogenesis. 2013 34:2716-25. (IP; Human) [Full Text Article] [PubMed:23892603]
9
Increased PD-L1 expression in erlotinib-resistant NSCLC cells with MET gene amplification is reversed upon MET-TKI treatment. Christina Demuth, Morten Nørgaard Andersen, Kristine Raaby Jakobsen, Anne Tranberg Madsen, Boe Sandahl Sørensen. Oncotarget. 2017 September;8:68221-68229. [Full Text Article] [PubMed:28978110] [PMC:PMC5620250] Related Antibodies: LS-C6611.
10
Temporal regulation of EGF signalling networks by the scaffold protein Shc1. Zheng Y, Zhang C, Croucher DR, Soliman MA, St-Denis N, Pasculescu A, Taylor L, Tate SA, Hardy WR, Colwill K, Dai AY, Bagshaw R, Dennis JW, Gingras AC, Daly RJ, Pawson T. Nature. 2013 Jul;499:166-71. [Full Text Article] [PubMed:23846654] Related Antibodies: LS-C6640.
11
Dasatinib and Doxorubicin Treatment of Sarcoma Initiating Cells: A Possible New Treatment Strategy. Aggerholm-Pedersen N, Demuth C, Safwat A, Meldgaard P, Kassem M, Sandahl Sorensen B. Stem cells international. 2016 2016:9601493. (WB; Human) [Full Text Article] [PubMed:26788073] [PMC:PMC4693025] Related Antibodies: LS-C6611.
more

☰ Filters
Products
Proteins (41)
Over-Expression Cell Culture Supernatant (1)
Over-Expression Lysate (7)
Recombinant (33)
EGFR (41)
No (41)
6His, C-terminus (4)
6His, N-terminus (3)
DDK (Flag)-His, C-terminus (1)
DDK,C-terminus (2)
Fc (1)
Fc, C-terminus (5)
GST (1)
GST, N-terminus (2)
His (2)
His, C-Terminal (2)
His, N-terminus (2)
His,C-terminus (2)
His-AVI, C-terminus (1)
His-GST (1)
His-S (1)
His-T7 (1)
Myc-DDK (Flag) (7)
Myc-DDK (Flag), C-terminus (2)
Human (34)
Mouse (3)
Rat (1)
293T Cells (3)
Baculovirus (1)
CHO Cells (2)
E. coli (5)
HEK 293 Cells (12)
Human Cells (6)
Mammalian Cells (5)
Sf9 Cells (4)
Wheat Germ Extract (3)
Purified (8)
Low endotoxin level (17)
Biologically active (1)
Select
CHO Cells
His, C-Terminal
Biologically active
Less than 0.2 EU/µg protein (determined by LAL method).
95-115 kDa (SDS-PAGE)
50 µg/$402; 10 µg/$296; 1 mg/$1,933
Select
Sf9 Cells
His, C-Terminal
Less than 0.2 EU/µg protein (determined by LAL method).
80 kDa (SDS-PAGE)
50 µg/$402; 10 µg/$296; 1 mg/$1,933
Select
HEK 293 Cells
6His, N-terminus
100 kDa
200 µl/$283
Select
CHO Cells
None
Less than 0.1 ng/µg of protein (less than 1EU/µg).
97.5 kDa
2 µg/$268; 10 µg/$349
EGFR Protein - Recombinant Epidermal Growth Factor Receptor By SDS-PAGE
Select
E. coli
His-S
37.5 kDa
10 µg/$276; 50 µg/$412; 100 µg/$657; 200 µg/$822; 1 mg/$1,905; 500 µg/$1,455; 5 mg/$2,871; 2 mg/$2,090
EGFR Protein - Recombinant Epidermal Growth Factor Receptor By SDS-PAGE
Select
E. coli
His-T7
22.3 kDa
10 µg/$278; 50 µg/$422; 100 µg/$672; 200 µg/$842; 1 mg/$1,934; 500 µg/$1,480; 5 mg/$2,941; 2 mg/$2,119
Select
Human Cells
Fc, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
65.8kD
10 µg/$288; 50 µg/$442; 500 µg/$1,585; 1 mg/$2,157
Select
Human Cells
6His, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
39.7kD
10 µg/$288; 50 µg/$442; 500 µg/$1,585; 1 mg/$2,157
Select
Human Cells
6His, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
69.6kD
10 µg/$321; 50 µg/$534; 500 µg/$1,585; 1 mg/$2,353
Select
Human Cells
Fc, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
95.7kD
10 µg/$281; 50 µg/$395; 500 µg/$1,585; 1 mg/$2,157
EGFR Protein - 12.5% SDS-PAGE Stained with Coomassie Blue.
Select
Wheat Germ Extract
GST, N-terminus
10 µg/$479; 25 µg/$670
EGFR Protein - 12.5% SDS-PAGE Stained with Coomassie Blue.
Select
Wheat Germ Extract
GST, N-terminus
10 µg/$479; 25 µg/$670
Select
Baculovirus
His-GST
Less than 1.0 EU/µg protein (determined by LAL method).
89.1 kDa
50 µg/$707
Select
Human Cells
His
Less than 1.0 EU/µg protein (determined by LAL method).
71 kDa
100 µg/$721
EGFR Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
HEK 293 Cells
Myc-DDK (Flag)
66.9 kDa
100 µg/$710
EGFR Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
HEK 293 Cells
Myc-DDK (Flag)
42.4 kDa
100 µg/$494
Select
293T Cells
Myc-DDK (Flag)
134.7 kDa
20 µg/$215
EGFR Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
293T Cells
Myc-DDK (Flag)
66.9 kDa
20 µg/$215
EGFR Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
293T Cells
Myc-DDK (Flag)
42.4 kDa
20 µg/$150
EGFR Protein - Purified recombinant protein EGFR was analyzed by SDS-PAGE gel and Coomassie Blue Staining
Select
HEK 293 Cells
Myc-DDK (Flag)
42.4 kDa
20 µg/$1,107
EGFR Protein
Select
Sf9 Cells
His,C-terminus
71 kDa
20 µg/$677
EGFR Protein
Select
Sf9 Cells
DDK,C-terminus
134 kDa
20 µg/$677
EGFR Protein - Recombinant Human EGFR Protein (His Tag)
Select
E. coli
His, N-terminus
18.2kDa
20 µg/$270; 100 µg/$390
Select
HEK 293 Cells
Myc-DDK (Flag)
134.7 kDa
100 µg/$710
Select
Mammalian Cells
Fc, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
95.7 kDa
10 µg/$281; 50 µg/$389
Viewing 1-25 of 41 product results


Filtered By:
Products: Proteins


If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.

PLEASE NOTE

For RESEARCH USE ONLY. Intended for use by laboratory professionals. Not intended for human diagnostic or therapeutic purposes.

The data on this page has been compiled from LifeSpan internal sources, the National Center for Biotechnology Information (NCBI), and The Universal Protein Resource (UniProt).